Management of low and high-grade dysplasia in inflammatory bowel disease: The gastroenterologists' perspective and current practice in the United Kingdom

European Journal of Gastroenterology and Hepatology

Volumn 17, Issue 12, 2005, Pages 1317-1324

  Thomas, Titus ^a   Nair, Prakash ^b   Dronfield, Mike W ^b   Mayberry, John F ^a,c  

^a UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

^b PETERBOROUGH DISTRICT HOSPITAL   (United Kingdom)

^c LEICESTER GENERAL HOSPITAL   (United Kingdom)

Author keywords

Colorectal cancer; Dysplasia; Inflammatory bowel disease

Indexed keywords

CANCER RISK; CLINICAL PRACTICE; COLON RESECTION; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE COURSE; DYSPLASIA; ENTERITIS; HEALTH SURVEY; HUMAN; MEDICAL SOCIETY; PRIORITY JOURNAL; REVIEW; UNITED KINGDOM;

ATTITUDE OF HEALTH PERSONNEL; CHRONIC DISEASE; COLECTOMY; COLONOSCOPY; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; GREAT BRITAIN; HUMANS; INFLAMMATORY BOWEL DISEASES; POPULATION SURVEILLANCE; PRECANCEROUS CONDITIONS; PROFESSIONAL PRACTICE; QUESTIONNAIRES;

EID: 29244443965     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200512000-00009     Document Type: Review

References (33)

1. Langholz E, Munkholm P, Davidsen M, Binder V. Colorectal cancer risk and mortality in patients with ulcerative colitis: factors determining risk. Gastroenterology 1992; 103:1444-1451.
2. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001; 48:526-535.
3. Lindberg B, Persson B, Veress B, Ingelman-Sundberg H, Granquist S. Twenty years' of colonoscopic surveillance of patients with ulcerative colitis. Detection of dysplasia and malignant transformation. Scand J Gastroenterol 1996; 31:1195-1204.
4. Choi PM, Zelig MP. Similarity of colorectal cancer in CD and UC. Implications for carcinogenesis and prevention. Gut 1994; 35:950-954.
5. Lofberg R, Brosstrom O, Karlen P, Tribukait B, Ost A. Colonoscopic surveillance in longstanding total ulcerative colitis - a 15-year follow-up study. Gastroenterology 1990; 99:1021-1031.
6. Lashner BA, Silverstein MD, Hanauer SB. Hazard rated for dysplasia and cancer in ulcerative colitis. Results from a surveillance program. Dig Dis Sci 1989; 34:1536-1541.
7. Lennard-Jones JE, Morson BC, Ritchie JK, Williams CB. Cancer surveillance in ulcerative colitis. Experience over 15 years. Lancet 1983; ii:149-152.
8. Blackstone MO, Riddell RH, Rogers BH, Levin B. Dysplasia associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy. Gastroenterology 1981; 80:366-374.
9. Connell WR, Lennard-Jones JE, Williams CB, Talbot CI, Price AB, Wilkinson HK. Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. Gastroenterology 1994; 107:934-944.
10. Lim CH, Dixon MF, Vail A, Forman JD, Lynch DA, Axon AT. Ten year follow up of ulcerative colitis patients with and without low-grade dysplasia. Gut 2003; 52:1127-1132.
11. Befrits R, Ljung T, Jaramillo E, Rubio C. Low-grade dysplasia in extensive long standing inflammatory bowel disease. Dis Col Rectum 2002; 45:615-620.
12. Lynch DA, Lobo AJ, Sabala GM, Dixon MF, Axon ATR. Failure of colonoscopic surveillance in ulcerative colitis. Gut 1993; 34:1075-1080.
13. Rutegard J, Ahgren L, Stenling R, Janunger KG. Ulcerative colitis. Cancer surveillance in an unselected population. Scand J Gastroenterol 1988; 23:139-145.
14. Ullman TA, Loftus VE, Kakar S, Burgart LJ, Sandborn WH, Tremaine WJ, et al. The fate of low-grade dysplasia in ulcerative colitis. Am J Gastroenterol 2002; 97:922-927.
15. Eaden AJ, Ward AB, Mayberry JF. How gastroenterologists screen for colonic cancer in ulcerative colitis: an analysis of performance. Gastrointest Endosc 2000; 51:123-128.
16. Bernstein CN, Weinstein MW, Levine SD, Shanahan F. Physicians' perceptions of dysplasia and approaches to surveillance colonoscopy in ulcerative colitis. Am J Gastroenterol 1995; 90:2106-2114.
17. Eaden AJ, Mayberry JF. Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease. Gut 2002; 51 (suppl 5):V10-V12.
18. Winawer S, Fletcher R, Bond J, Burt R, Ferrucci J, Ganiats T, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale-update based on new evidence. Gastroenterology 2003; 124:544-560.
19. Taylor BA, Pemberton JH, Carpenter HA, Levin KE, Schroeder KW, Welling DR, et al. Dysplasia in chronic ulcerative colitis: implications for colonoscopic surveillance. Dis Col Rectum 1992; 35:950-956.
20. Johnson E, Carlsen E, Nazir M, Nygaard K. Morbidity and functional outcome after restorative proctocolectomy for ulcerative colitis. Eur J Surg 2001; 167:40-45.
21. Dixon MF, Brown LTR, Gilmour HM. Observer variation in the assessment of dysplasia in ulcerative colitis. Histopathology 1988; 95:668-675.
22. British Society of Gastroenterology. Handbook 2003. London: BSG Secretariat; 2003.
23. Fleiss JL. Statistical methods for rates and proportions. 2nd ed. New York: Wiley; 1981.
24. Woolrich AJ, DaSilva MD, Korelitz BI. Surveillance in the routine management of ulcerative colitis: the predictive value of low-grade dysplasia. Gastroenterology 1992; 103:431-438.
25. Riddell RH, Goldman H, Ransohoff DF, Appelman HD, Fenoglio CM, Haggitt RC, et al. Dysplasia in inflammatory bowel disease: standardised classification with provisional clinical applications. Hum Pathol 1983; 14:931-968.
26. Ullman T, Croog V, Harpaz N, Sachar D, Itzkowitz S. Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis. Gastroenterology 2003; 125:1311-1319.
27. Griffiths AM, Sherman PM. Colonoscopic surveillance for cancer in ulcerative colitis: a critical review. J Paediatr Gastroenterol Nutr 1997; 24:202-210.
28. Gorfine RS, Bauer JJ, Harris TM, Kreel I. Dysplasia complicating chronic ulcerative colitis. Is immediate colectomy warranted? Dis Col Rectum 2000; 43:1575-1581.
29. Lewis MC, Sains P, Marks G. Surveillance for dysplasia in ulcerative colitis: a survey of current UK practice. Colorectal Dis 2002; 1 (suppl 4):23.
30. Rubin CE, Haggitt RC, Burmer GC, Brentnull TA, Stevens AC, Levine DS. DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis. Gastroenterology 1992; 103:1611-1620.
31. Rosenstock E, Farmer RG, Petras R, Sivak Jr. VM, Rankin BG, Sullivan HB. Surveillance for colonic carcinoma in ulcerative colitis. Gastroenterology 1985; 89:1342-1346.
32. Bernstein CN, Shanahan F, Wienstein WM. Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? Lancet 1994; 343:71-74.
33. Schlempler RJ, Riddell RH, Kato Y, Burcharol F, Cooper HS, Dawsey SM, et al. The Vienna classification of gastrointestinal neoplasia. Gut 2000; 24:167-176.